Vilitra 60 mg is classified as a phosphodiesterase type 5 (PDE5) inhibitor because of its mechanism of action and its intended use in treating certain medical conditions. Phosphodiesterase type 5 (PDE5) inhibitors are a class of medications that work by blocking the action of the enzyme PDE5. This enzyme is primarily found in the smooth muscle cells of the penis and is involved in the regulation of blood flow. By inhibiting PDE5, these medications promote the relaxation of blood vessel walls and increase blood flow to specific areas of the body, particularly the penis. This increased blood flow can help men achieve and maintain an erection, which is why PDE5 inhibitors are commonly used to treat erectile dysfunction (ED). Vilitra 60 Mg contains the active ingredient Vardenafil. Vardenafil is a potent PDE5 inhibitor that enhances the effects of nitric oxide, a chemical that is naturally produced in the body and promotes vasodilation (widening of blood vessels). When a man is sexually aroused, nitric oxide is released in the penile tissues, which leads to increased blood flow to the penis and ultimately results in an erection. However, in individuals with ED, this process is impaired, and PDE5 inhibitors like Vardenafil help to restore and enhance the natural response to sexual stimulation. In summary, Vilitra 60 mg is classified as a PDE5 inhibitor because it contains Vardenafil, a compound that inhibits the PDE5 enzyme, thereby promoting increased blood flow to the penis and aiding in the treatment of erectile dysfunction.
Call: 876-927-9941–3 .
